Truist Securities Raises Price Target on Gilead Sciences, Inc. (GILD) to $145, Keeps Buy Rating

by | Feb 3, 2026 | Uncategorized

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments